Skip to content
10-K

Annual Report

Alto Neuroscience, Inc. ANRO

0001999480-26-000002

← back to feed
Filed
Mar 16, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 9, 2026 31.95M sh
Shares Diluted FY 2025 · Dec 31, 2025 28.85M sh
Shares Diluted FY 2025 · Dec 31, 2024 24.6M sh
Capex FY 2025 · Dec 31, 2025 $24K
Capex FY 2025 · Dec 31, 2024 $2.08M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$51.77M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$47.42M
Long Term Debt FY 2025 · Dec 31, 2025 $16.17M
Long Term Debt FY 2025 · Dec 31, 2024 $10.25M
Short Term Debt FY 2025 · Dec 31, 2025 $585K
Short Term Debt FY 2025 · Dec 31, 2024 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $176.48M
Cash And Equivalents FY 2025 · Dec 31, 2024 $168.23M
Stockholders Equity FY 2025 · Dec 31, 2025 $151.14M
Stockholders Equity FY 2025 · Dec 31, 2024 $151.46M
Stockholders Equity FY 2025 · Dec 31, 2023 −$71.67M
Current Liabilities FY 2025 · Dec 31, 2025 $11.33M
Current Liabilities FY 2025 · Dec 31, 2024 $10.01M
Total Liabilities FY 2025 · Dec 31, 2025 $33.55M
Total Liabilities FY 2025 · Dec 31, 2024 $26.08M
Current Assets FY 2025 · Dec 31, 2025 $177.72M
Current Assets FY 2025 · Dec 31, 2024 $169.34M
Total Assets FY 2025 · Dec 31, 2025 $184.69M
Total Assets FY 2025 · Dec 31, 2024 $177.54M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.19
Eps Diluted FY 2025 · Dec 31, 2024 −$2.50
Eps Basic FY 2025 · Dec 31, 2025 −$2.19
Eps Basic FY 2025 · Dec 31, 2024 −$2.50
Sga Expense FY 2025 · Dec 31, 2025 $20.75M
Sga Expense FY 2025 · Dec 31, 2024 $21.61M
Rd Expense FY 2025 · Dec 31, 2025 $45.62M
Rd Expense FY 2025 · Dec 31, 2024 $47M
Net Income FY 2025 · Dec 31, 2025 −$63.24M
Net Income FY 2025 · Dec 31, 2024 −$61.43M
Operating Income FY 2025 · Dec 31, 2025 −$66.36M
Operating Income FY 2025 · Dec 31, 2024 −$68.61M